Literature DB >> 16807428

1,3-beta-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid.

Monique A S H Mennink-Kersten, Adilia Warris, Paul E Verweij.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16807428     DOI： 10.1056/NEJMc053340

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  33 in total

Review 1.  Fungal diagnostics in pneumonia.

Authors:  Erika D Lease; Barbara D Alexander
Journal:  Semin Respir Crit Care Med       Date:  2011-12-13       Impact factor: 3.119

2.  The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.

Authors:  Barbara D Alexander; P Brian Smith; R Duane Davis; John R Perfect; L Barth Reller
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

3.  Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients.

Authors:  Johan Maertens; Griet Huysmans; Koen Theunissen
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

4.  Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study.

Authors:  Greet De Vlieger; Katrien Lagrou; Johan Maertens; Eric Verbeken; Wouter Meersseman; Eric Van Wijngaerden
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

5.  Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.

Authors:  J Acosta; M Catalan; A del Palacio-Pérez-Medel; J-C Montejo; J De-La-Cruz-Bértolo; M-D Moragues; J Pontón; M A Finkelman; A del Palacio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-03       Impact factor: 3.267

6.  How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.

Authors:  H Hammarström; N Kondori; V Friman; C Wennerås
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-09       Impact factor: 3.267

7.  Monitoring Anti-Pythium insidiosum IgG Antibodies and (1→3)-β-d-Glucan in Vascular Pythiosis.

Authors:  Navaporn Worasilchai; Nitipong Permpalung; Pakawat Chongsathidkiet; Asada Leelahavanichkul; Alberto Leonel Mendoza; Tanapat Palaga; Rangsima Reantragoon; Malcolm Finkelman; Pranee Sutcharitchan; Ariya Chindamporn
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

8.  Strategy for overcoming serum interferences in detection of serum (1,3)-β-D-glucans.

Authors:  Boualem Sendid; Nadine Francois; Vanessa Decool; Julien Poissy; Daniel Poulain
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

9.  Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit.

Authors:  G Lo Cascio; R Koncan; G Stringari; A Russo; A Azzini; A Ugolini; M Ligozzi; E Polati; G Cornaglia; E Concia; V Schweiger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-13       Impact factor: 3.267

10.  Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species.

Authors:  Eiman Mokaddas; Mona H A Burhamah; Zia U Khan; Suhail Ahmad
Journal:  BMC Infect Dis       Date:  2010-10-06       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.